Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Zhongzhi Pharmaceutical Holdings Limited ( (HK:3737) ) is now available.
Zhongzhi Pharmaceutical Holdings Limited has announced a change in its board of directors, effective April 10, 2025. Mr. Zhu Shangheng has been appointed as an independent non-executive director, taking over roles previously held by Mr. Wong Kam Wah, who has resigned. Mr. Zhu brings extensive legal expertise, particularly in pharmaceutical law, which could enhance the company’s governance and risk management capabilities.
More about Zhongzhi Pharmaceutical Holdings Limited
Zhongzhi Pharmaceutical Holdings Limited operates within the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is listed on the Hong Kong Stock Exchange and is incorporated in the Cayman Islands.
YTD Price Performance: -9.09%
Average Trading Volume: 296,280
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$762.3M
See more data about 3737 stock on TipRanks’ Stock Analysis page.